Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spotting the vulnerable: a risk score for post-surgery brain fog in the elderly

NCT ID NCT07719712

Knowledge-focused Sponsor: Muğla Sıtkı Koçman University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study is testing whether a risk score can predict which older adults will experience confusion or memory problems after a common urological procedure. Researchers will follow 150 patients aged 65 and older undergoing transurethral resection, using cognitive tests before and after surgery. The goal is to identify factors that make some patients more vulnerable, so doctors can tailor care and potentially reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple tool to identify elderly patients at higher risk of confusion or memory problems after surgery, allowing for more personalized care.
What could go wrong
This is an observational study, not a treatment trial, so it cannot directly improve outcomes. The risk score may not be accurate enough for routine use and will need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of patients aged 65 years and older undergoing transurethral resection at Mugla Training and Research Hospital. These patients represent an elderly surgical population at risk for postoperative cognitive dysfunction and delirium. Participants are enrolled consecutively according to eligibility criteria and followed throughout the perioperative period.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥65 years * Scheduled for transurethral resection procedure * ASA physical status I-III * Able to provide informed consent * Adequate cognitive function to complete preoperative assessment Exclusion Criteria: * Pre-existing diagnosis of dementia or severe cognitive impairment (MoCA \<18) * Severe visual or hearing impairment preventing cognitive assessment * History of psychiatric disease requiring antipsychotic or sedative medication * Neurological disorders associated with increased delirium risk (e.g., Parkinson's disease, epilepsy) * Inability to complete study assessments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive dysfunction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction delirium Emergence Delirium Postoperative Cognitive Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive dysfunction Postoperative cognitive dysfunction Postoperative delirium

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Muğla Training and Research Hospital

    RECRUITING

    Muğla, 48000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.